No need to get narky with me and please get your facts straight.
PNV, through its JV NovoSkin designed/invented BTM/MTX, not CSIRO. Whilst work on BTM started under Xceed Biotechnology's ownership, BTM's development (with the help of BioSA) mostly took place after Metabolic/Calzada bought PNV.
To this day, PNV have not been able to launch another product using the NovoSorb platform. This may explain your confusion.
PNV - Banter and General Comments, page-10020
-
- There are more pages in this discussion • 2,052 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.37 |
Change
0.080(3.49%) |
Mkt cap ! $1.635B | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.44 | $2.31 | $4.848M | 2.032M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 31280 | $2.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 6793 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |